(Q38452045)

English

Loss of expression of the putative tumor suppressor NES1 gene in biopsy-proven ductal carcinoma in situ predicts for invasive carcinoma at definitive surgery

scientific article published on July 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Loss of expression of the putative tumor suppressor NES1 gene in biopsy-proven ductal carcinoma in situ predicts for invasive carcinoma at definitive surgery (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

invasive carcinoma

1 reference

based on heuristic

inferred from title

ductal carcinoma

1 reference

based on heuristic

inferred from title

author name string

Michael J Yunes

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Andrew C Neuschatz

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Linda E Bornstein

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Stephen P Naber

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Vimla Band

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

David E Wazer

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

language of work or name

0 references

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

56

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

653-657

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900068-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900068-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900068-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900068-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(03)00068-3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38452045&oldid=1760295899"